Erlangen, Germany 10/6/08—Siemens has acquired SG Wasseraufbereitung und Regenerierstation GmbH (SG Water Treatment and Regeneration) for an undisclosed amount. SG Water provides water treatment solutions for laboratories and industrial organizations, including ultra pure water systems and reverse osmosis equipment for the lab. The company will join Siemens Water Technologies, part of Siemens’ Industry Solutions Division. […]
R&D spending in Hungary increased 3.3% last year to HUF 245.7 billion ($1,483 million) to make up 0.97% of GDP, down from 1% in 2006. Private funding accounted for 44% of R&D expenditures, the government represented 44%, while foreign funding made up 11% and nonprofits represented 1%. Basic and applied research accounted for 16% of […]
Palo Atlo, CA 10/14/08—Varian has announced that it expects its sales for the fiscal year ended October 3 to exceed $1 billion. The company forecasts non-GAAP adjusted diluted EPS of more than $2.80, compared to previous guidance of $2.74 plus or minus $0.05. GAAP diluted EPS is expected to exceed $2.11, compared to the previous […]
Donations to charities and other nonprofit institutions that fund medical research could be at risk due to the economic crisis. According to the Center on Philanthropy at the University of Indiana, the level of donations made to charities correlates with the fortunes of the stock markets, but any effects from the current crisis would not […]
Cleveland, OH 10/1/08—Parker Hannifin has purchased Hargraves Technology. Hargraves designs and manufactures miniature liquid and pneumatic diaphragm pumps, control valves and system solutions for medical devices, life science analytical instruments, as well as diagnostics, gas detection and printing systems. Based in Mooresville, North Carolina, Hargraves had 2007 sales of $14 million. Parker Hannifin will form […]
According to South Africa’s “National Survey of Research and Experimental Development: the country’s gross domestic expenditure on R&D totaled ZAR 16,520.6 million ($1.95 billion), 0.95% of GDP, in 2006-2007 for a nominal annual increase of 16.8%. Engineering sciences, natural sciences, and medical and health sciences comprised 20.9%, 20.3% and 15.1% of R&D, respectively. Applied sciences […]
This month, Sweden announced the largest R&D investment in its history. The Swedish government’s 2009 budget commits SEK 2.4 billion ($364 million) in 2009 to research funding. Such funding will reach SEK 5 billion in 2012. The funding includes the elimination of the value added tax on education. Medicine, technology and the climate will receive […]
India’s Central Drugs Standard Control Organization (CDSCO) is preparing plans to enable foreign drug companies to conduct phase I clinical trials in the country, according to a government official. Currently, only Indian companies can conduct phase 0 and I trials domestically. KPMG estimates that India’s clinical research market was worth $200 million in 2007 and […]
Company Announcements Caliper Life Sciences is bundling DiscovRx’s cell-based GPCR assays with its LabChip platforms. Amnis named Gene Company as the Chinese distributor of its ImageStream in May. Fluxion Biosciences signed an exclusive distribution agreement with Bucher Biotec AG for Switzerland. Accuri Cytometers licensed a time-limited, customized version of De Novo Software’s FCS Expression software […]
New York, NY 9/22/08; South San Francisco, 9/26/08—Citing market instability, Fluidigm has withdrawn its registration statement for an IPO. Fluidigm, which develops microfluidic systems for drug development (see IBO 4/30/08), had originally planned to begin trading on September 19, but postponed the offering several times. Fluidigm had planned to raise $79.5 million in an offering […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
